Scott Boyd, MD PhD
Key Documents
Contact Information
-
Clinical Offices
Department of Pathology 300 Pasteur Dr L235 MC 5324 Stanford, CA 94305 Tel Work (650) 724-0107 Fax (650) 725-6902Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Hematopathology
Honors and Awards
- New Scholar Award in Aging, Ellison Medical Foundation (2011)
- Walter V. and Idun Berry Fellowship, Stanford University (2008)
- Harry B. Neustein Award, Society of Pediatric Pathology (2008)
- Young Investigator Award, Society of Pediatric Pathology (2007)
- Rhodes Scholarship, University of Oxford (1992-4)
Professional Education
| Fellowship: | Stanford Hospital & Clinics CA (2008) |
| Residency: | Stanford Hospital & Clinics CA (2009) |
| Medical Education: | Harvard Medical School MA (2005) |
| Ph.D.: | M.I.T., Biology (2004) |
| B.A.: | University of Oxford, English Literature (1994) |
Postdoctoral Advisees
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
The lymphocytes of the human immune system share some biological properties with human cancers: in each case, there are subpopulations of cells whose genomes are rearranged and mutated compared to other cells in the body. Our goal is to understand the genotype-phenotype relationships in lymphoid cells that determine the behavior of human diseases. We apply new analytical methods, particularly high-throughput DNA sequencing, in parallel with functional assays to tackle this broad challenge. Our initial focus has been on defining B and T cell populations by deep sequencing of V(D)J rearrangements in clinical samples from healthy individuals as well as patients with immune-mediated diseases or lymphoid malignancies.
Clinical Trials
- Integrated Whole-Genome Analysis of Hematologic Disorders Recruiting
- Understanding Allergies Recruiting
Publications
- Measurement and Clinical Monitoring of Human Lymphocyte Clonality by Massively Parallel V-D-J Pyrosequencing Science Translational Medicine. 2009; (12)
- The Inference of Phased Haplotypes for the Immunoglobulin H Chain V Region Gene Loci by Analysis of VDJ Gene Rearrangements. J Immunol. 2012; (3): 1333-40
- Determinants of nucleosome organization in primary human cells. Nature. 2011; (7352): 516-20
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc Natl Acad Sci U S A. 2011; (52): 21194-9
- Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med. 2011; (11): 2237-49

